Recurrent vulvovaginal candidiasis |
| |
| Affiliation: | 1. Center for Molecular and Clinical Epidemiology, University of Michigan, School of Public Health, Ann Arbor;2. Independent, Lausanne, Switzerland;1. Department of Laboratory Science, Peking University Shenzhen Hospital, Shenzhen, China;2. Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen 518036, China;1. Department of Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 760, 51007 Fintas, Kuwait;2. Microbiology Unit, Department of Laboratories, Farwania Hospital, Kuwait;3. Department of Obstetrics and Gynecology, Farwania Hospital, Kuwait;1. Hospital Materno Infantil Ramón Sardá, Esteban de Luca 2151, CP 1246 Buenos Aires, Argentina;2. Instituto of Microbiología y Parasitología Médica, Universidad de Buenos Aires-Consejo Nacional de Investigaciones Científicas y Técnicas (IMPaM, UBA-CONICET), Paraguay 2155, piso 11, CP 1121ABG Buenos Aires, Argentina;1. Department of Laboratory Medicine, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium;2. Department of Microbiology and Immunology, KU Leuven – University of Leuven, Herestraat 49, 3000 Leuven, Belgium;1. Institut supérieur des sciences de la santé, université Nazi Boni, 01 BP 1091, Bobo-Dioulasso, Burkina Faso;2. Département des laboratoires, CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso;3. Centre Muraz, Bobo-Dioulasso, Burkina Faso;4. CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso;5. Jhpiego, Baltimore, United States;6. Unité de formation et de recherche en sciences pharmaceutiques et biologiques et médicales, université Félix Houphouet Boigny, Abidjan, Côte d’Ivoire |
| |
| Abstract: | PurposeRecurrent vulvovaginal candidiasis (RVVC), multiple episodes of vulvovaginal candidiasis (VVC; vaginal yeast infection) within a 12-month period, adversely affects quality of life, mental health, and sexual activity. Diagnosis is not straightforward, as VVC is defined by the combination of often nonspecific vaginal symptoms and the presence of yeast—which is a common vaginal commensal. Estimating the incidence and prevalence is challenging: most VVC is diagnosed and treated empirically, the availability for purchase of effective therapies over the counter enables self-diagnosis and treatment, and the duration of the relatively benign VVC symptoms is short, introducing errors into any estimates relying on medical records or patient recall.MethodsWe evaluate current estimates of VVC and RVVC and provide new prevalence estimates using data from a 2011 seven-country (n = 7345) internet panel survey on VVC conducted by Ipsos Health (https://www.ipsos.com/en). We also evaluate information on VVC-associated visits using the National Ambulatory Medical Care Survey.ResultsThe estimated probability of VVC by age 50 varied widely by country (from 23% to 49%, mean 39%), as did the estimated probability of RVVC after VVC (from 14% to 28%, mean 23%).ConclusionsHowever estimated, the probability of RVVC was high suggesting RVVC is a common condition. |
| |
| Keywords: | Vulvovaginal candidiasis Recurrent Prevalence Incidence Diagnosis |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
